Results 51 to 60 of about 168,114 (189)

The establishment and application of MOG-IgG-mediated complement-dependent in vitro demyelination model [PDF]

Xin yixue, 2022
Objective To explore the pathogenic mechanism of myelin oligodendrocyte glycoprotein-IgG（MOG-IgG）associated disorders （MOGAD） and screen the treatment drugs by establishing the MOGAD in vitro demyelination model.
Chen Yashuang, Xiao Xiuqing, Wang Shisi, Mo Yongxin, Sun Xiaobo, Zhong Xiaofen, Peng Lisheng
doaj   +1 more source

Comparison of glial fibrillary acidic protein-immunoglobulin G-associated myelitis with myelin oligodendrocyte glycoprotein-immunoglobulin G-associated myelitis

Frontiers in Neurology, 2023
ObjectiveGlial fibrillary acidic protein-immunoglobulin G (GFAP-IgG)-associated myelitis and myelin oligodendrocyte glycoprotein-IgG (MOG-IgG)-associated myelitis have rarely been compared. Therefore, this study aimed to explore the clinical, laboratory,
Mengyang Sun, Hao Liu, Bingqing Zhu, Yang Liu, Aijia Li, Limei Wang   +5 more
doaj   +1 more source

Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients [PDF]

, 2016
Background Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been reported in patients with aquaporin-4 antibody (AQP4-IgG)-negative neuromyelitis optica spectrum disorders (NMOSD).
Schumacher, Sophie, Lacheta, Anna, Zimmermann, Hanna, Oertel, Frederike C. [u.v.m.], Mikolajczak, Janine, Pache, Florence   +5 more
core   +1 more source

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein

Frontiers in Neuroscience, 2023
BackgroundThe autoantibody to myelin oligodendrocyte glycoprotein (MOG), a component of the central nervous system myelin, has been identified in a subset of demyelinating diseases.
Kuniko Kohyama, Hiroya Nishida, Kimihiko Kaneko, Tatsuro Misu, Ichiro Nakashima, Hiroshi Sakuma   +5 more
doaj   +1 more source

Optomyelitis associated with the presence of antibodies to myelin oligodendrocyte glycoprotein. Case report

Consilium Medicum, 2022
Antibodies to myelin-oligodendrocyte glycoprotein (anti-MOG-IgG) is a specific biomarker that has been detected in peripheral blood from children with acute multiple encephalomyelitis (ADEM) as well as in adults with aquaporin-4 (AQP4), associated with ...
Anastasiia K. Kalashnikova, Nataliia L. Sheremet, Natalia A. Andreeva, Nino V. Zhorzholadze, Irina A. Ronzina, Anna A. Kaloshina   +5 more
doaj   +1 more source

Supplemental Table2 - Supplemental material for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders

, 2018
Supplemental material, Supplemental Table2 for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders by Susanna Asseyer, Felix Schmidt, Claudia Chien, Michael Scheel, Klemens Ruprecht, Judith Bellmann-Strobl, Alexander U ...
Judith Bellmann-Strobl (96062), Michael Scheel (445740), Alexander U Brandt (5705579), Felix Schmidt (312801), Friedemann Paul (25657), Susanna Asseyer (5705573), Claudia Chien (5705576), Klemens Ruprecht (187598)   +7 more
core   +1 more source

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin [PDF]

, 2016
Background: Antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) have been suggested to play a role in a subset of patients with neuromyelitis optica and related disorders.
Hümmert, Martin W., Schwarz, Alexander, Korporal-Kuhnke, Mirjam, Wildemann, Brigitte, Buttmann, Mathias, Haas, Jürgen, Schanda, Kathrin, Stich, Oliver, Jarius, Sven, Pitarokoili, Kalliopi, Fechner, Kai, Paul, Friedemann, Winkelmann, Alexander, Asgari, Nasrin, Pache, Florence, Lillevang, Soeren Thue, Franciotta, Diego, Kuchling, Joseph, Zimmermann, Hanna, Reindl, Markus, Aktas, Orhan, Capobianco, Marco, Trebst, Corinna, Ruprecht, Klemens, Ringelstein, Marius, Kleiter, Ingo, Beume, Lena-Alexandra, Brandt, Alexander U., Borisow, Nadja   +28 more
core   +7 more sources

Supplemental Table1 - Supplemental material for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders

, 2018
Supplemental material, Supplemental Table1 for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders by Susanna Asseyer, Felix Schmidt, Claudia Chien, Michael Scheel, Klemens Ruprecht, Judith Bellmann-Strobl, Alexander U ...
Judith Bellmann-Strobl (96062), Michael Scheel (445740), Alexander U Brandt (5705579), Felix Schmidt (312801), Friedemann Paul (25657), Susanna Asseyer (5705573), Claudia Chien (5705576), Klemens Ruprecht (187598)   +7 more
core   +1 more source

Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations. [PDF]

, 2023
Antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) or aquaporin 4 (AQP4-IgG) are associated with CNS inflammatory disorders. We directly compared MOG35-55-induced experimental autoimmune encephalomyelitis exacerbated by MOG- and AQP4-IgG (versus
Bagnoud, Maud, Salmen, Anke, Jeffrey L. Bennett, Hoepner, Robert, Robert Hoepner, Meli, Ivo, Massy, Marine, Andrew Chan, Bennett, Jeffrey L, Christopher Linington, Enzmann, Volker, Maud Bagnoud, Ivo Meli, Volker Enzmann, Anke Salmen, Chan, Andrew, Remlinger, Jana, Linington, Christopher, Jana Remlinger, Marine Massy   +19 more
core   +1 more source

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison

Clinical Ophthalmology, 2020
Chanomporn Narongkhananukul,1 Tanyatuth Padungkiatsagul,1 Panitha Jindahra,2 Chaiyos Khongkhatithum,3 Lunliya Thampratankul,3 Kavin Vanikieti1 1Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand ...
Narongkhananukul C, Padungkiatsagul T, Jindahra P, Khongkhatithum C, Thampratankul L, Vanikieti K   +5 more
doaj